Alkeus Pharmaceuticals

Alkeus Pharmaceuticals

MA - Cambridge
Pharmaceutical

Focus: Ophthalmics

Alkeus Pharmaceuticals is a life sciences company focused on Ophthalmics.

NeurologyOphthalmology
Employees
1-50
Total Funding
$1.5B
Open Jobs
3

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT02230228Phase 1 Safety Study of ALK-001 in Healthy Volunteers
Phase 1
Phase 2
Clinical Trials (1)
NCT04239625Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
Phase 2
Phase 2
Clinical Trials (1)
NCT02402660Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Phase 2
ALK-001 oral capsule
Geographic Atrophy
Phase 2/3
Clinical Trials (1)
NCT03845582Phase 2/3 Study of ALK-001 in Geographic Atrophy
Phase 2/3
Phase 3
Clinical Trials (1)
NCT07419334Study of ALK-001 on the Progression of Stargardt Disease
Phase 3

Open Jobs (3)

Interview Prep Quick Facts
Portfolio: 5 clinical trials
Open Roles: 3 active jobs

Hiring Trend

Stable
3
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles